Literature DB >> 19285273

Microparticles, thrombosis and cancer.

Anat Aharon1, Benjamin Brenner.   

Abstract

Microvesicles comprised of exosomes and microparticles are shed from both normal and malignant cells upon cell activation or apoptosis. Microvesicles promote clot formation, mediate pro-inflammatory processes, facilitate cell-to-cell interactions, transfer proteins and mRNA to cells, and induce cell signalling. Microparticles bearing tissue factor play a central role in coagulation initiation and thrombus formation. This chapter will review earlier studies which focus on the role of procoagulant microvesicles in cancer thrombogenicity, and discuss the effects of microvesicles on vascular cell dysfunction and angiogenesis. In addition, this chapter will present new findings which characterize the haemostatic balance of microparticles, and suggest a method that may potentially serve to predict a state of hypercoagulability in cancer patients. This chapter highlights the interplay between microvesicles, coagulation factors and cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285273     DOI: 10.1016/j.beha.2008.11.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  40 in total

1.  Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.

Authors:  Elham Hosseini-Beheshti; Steven Pham; Hans Adomat; Na Li; Emma S Tomlinson Guns
Journal:  Mol Cell Proteomics       Date:  2012-06-21       Impact factor: 5.911

2.  Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate.

Authors:  Johanna Zannoni; Natacha Mauz; Landry Seyve; Mathieu Meunier; Karin Pernet-Gallay; Julie Brault; Claire Jouzier; David Laurin; Mylène Pezet; Martine Pernollet; Jean-Yves Cahn; Fabrice Cognasse; Benoît Polack; Sophie Park
Journal:  Blood Adv       Date:  2019-06-25

Review 3.  Extracellular vesicles and blood diseases.

Authors:  Shosaku Nomura
Journal:  Int J Hematol       Date:  2017-01-27       Impact factor: 2.490

Review 4.  Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.

Authors:  James P K Armstrong; Margaret N Holme; Molly M Stevens
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

5.  Analysis of the thrombotic and fibrinolytic activities of tumor cell-derived extracellular vesicles.

Authors:  Ludovic Durrieu; Alamelu Bharadwaj; David M Waisman
Journal:  Blood Adv       Date:  2018-05-22

6.  Paracrine induction of endothelium by tumor exosomes.

Authors:  Joshua L Hood; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Lab Invest       Date:  2009-09-28       Impact factor: 5.662

Review 7.  Pancreatic cancer stem cell markers and exosomes - the incentive push.

Authors:  Sarah Heiler; Zhe Wang; Margot Zöller
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

8.  Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription.

Authors:  Jason M Aliotta; Mandy Pereira; Kevin W Johnson; Nicole de Paz; Mark S Dooner; Napoleon Puente; Carol Ayala; Kate Brilliant; David Berz; David Lee; Bharat Ramratnam; Paul N McMillan; Douglas C Hixson; Djuro Josic; Peter J Quesenberry
Journal:  Exp Hematol       Date:  2010-01-15       Impact factor: 3.084

Review 9.  Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure.

Authors:  Stéphane Flamant; Radia Tamarat
Journal:  Radiat Res       Date:  2016-07-26       Impact factor: 2.841

10.  Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs.

Authors:  Tian Sheng Chen; Ruenn Chai Lai; May May Lee; Andre Boon Hwa Choo; Chuen Neng Lee; Sai Kiang Lim
Journal:  Nucleic Acids Res       Date:  2009-10-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.